US29089Q1058
US29089Q1058
Emergent BioSolutions Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 705.200.000 | 1.013.600.000 | 30.4% |
| Cost of Revenue | 326.200.000 | 681.300.000 | 52.1% |
| Gross Profit | 379.000.000 | 332.300.000 | 14.1% |
| 266.700.000 | 413.800.000 | 35.5% | |
| Operating Income | 112.300.000 | -81.500.000 | 237.8% |
| Pretax Income | 82.800.000 | -142.900.000 | 157.9% |
| Net Income Common Stockholders | 52.600.000 | -190.600.000 | 127.6% |
| -- | -- | -- | |
| -- | -- | -- |